GEN-MKT-18-7897-A
Mar 2, 2017 | Blogs, Food / Beverage | 0 comments
As we settle into 2017, I can’t help but reflect on the previous year’s food safety. Take for example the legislative changes meant to contain contamination outbreaks like those happening in places like China, Singapore, and New Zealand. Over the past year, we have developed new methods that detect antibiotics in poultry feed, LC-MS/MS Analysis of Emerging Contaminants, and help set food standards in China. All the while developing more sophisticated technology to keep up with testing demands.
Changes like this do not come easy. At SCIEX, one must be on top of trends before they happen, and as such, our R&D department spent most of the year investing in this new vision and updating mass spectrometry instruments to meet the challenges of today’s food labs.
You can read more about mine and my colleague’s perspectives on emerging technologies in Asian Food Journal, in which we not only discuss product innovation and highlights but trends and opportunities too. Meanwhile, keep a look out for monthly blogs keeping you up to date on continuous trends.
The Take Away: Labs around the world are starting to migrate to High-Resolution MS workflows, particularly SWATH® Acquisition. Join me in adding your thoughts on what food and safety trends are coming this year by commenting below.
For research use only. Not for use in diagnostic procedures.
In biopharmaceutical development, sequence variants (SV) are considered an inherent risk of producing complex proteins in living systems. Sequence variants are unintended changes to the amino acid sequence of a biotherapeutic and can be caused by errors in transcription or translation in the host cell, or cell culture and process conditions. Detailed analysis of SVs is important in process and product development to ensure the drug’s safety and efficacy. Even low‑level sequence variants can have significant implications for product quality, safety, and efficacy, making their accurate detection and characterization a critical requirement across development, process optimization, and regulatory submission.
CE‑SDS remains a cornerstone assay for characterizing fragmentation, aggregation, and product‑related impurities in therapeutic proteins. UV detection has been the long‑standing standard. However, it frequently struggles with baseline noise, limited sensitivity for minor fragments, and subjective integration.
At SCIEX, innovation doesn’t stop at instruments; it extends to how you interact with your LC-MS/MS or CE systems every day. That’s why we’re excited to introduce the SCIEX Now spring 2026 improvements: a set of meaningful enhancements shaped directly by your feedback.
Posted by
You must be logged in to post a comment.
Share this post with your network